86 related articles for article (PubMed ID: 23114142)
21. A radio-resistant perforin-expressing lymphoid population controls allogeneic T cell engraftment, activation, and onset of graft-versus-host disease in mice.
Davis JE; Harvey M; Gherardin NA; Koldej R; Huntington N; Neeson P; Trapani JA; Ritchie DS
Biol Blood Marrow Transplant; 2015 Feb; 21(2):242-9. PubMed ID: 25459639
[TBL] [Abstract][Full Text] [Related]
22. [Hematopoietic reconstitution of recipient mice after mFasL-cDNA transfected hematopoietic cell transplantation].
Xu ZL; Shi QZ; Luo JS; Xia LP; Zou P
Zhonghua Er Ke Za Zhi; 2005 Apr; 43(4):284-7. PubMed ID: 15924722
[TBL] [Abstract][Full Text] [Related]
23. Bone marrow transplantation combined with mesenchymal stem cells induces immune tolerance without cytotoxic conditioning.
Wang Y; Liu J; Xu C; Zhang W; Bai L; Li N; Liu Y; Wang Y; Su Y; Hu D
J Surg Res; 2011 Nov; 171(1):e123-31. PubMed ID: 21920556
[TBL] [Abstract][Full Text] [Related]
24. [Effects of immature dendritic cells to express CCR7 on graft-versus-host disease in allogeneic bone marrow transplant mouse model].
Li DP; Wu JQ; Huang YH; Song LX; Gu HH; Gao CL; Li ZY; Pan XY; Xu KL
Zhonghua Xue Ye Xue Za Zhi; 2013 Sep; 34(9):782-7. PubMed ID: 24103877
[TBL] [Abstract][Full Text] [Related]
25. [Experimental study of donor natural killer cells reducing graft-versus-host disease and enhancing engraftment].
Huang CL; Liu T; Lu XX; Meng WT
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2006 Oct; 14(5):924-7. PubMed ID: 17096890
[TBL] [Abstract][Full Text] [Related]
26. Graft-facilitating doses of ex vivo activated gammadelta T cells do not cause lethal murine graft-vs.-host disease.
Drobyski WR; Majewski D; Hanson G
Biol Blood Marrow Transplant; 1999; 5(4):222-30. PubMed ID: 10465102
[TBL] [Abstract][Full Text] [Related]
27. [ALA-PDT alleviates graft-versus-host disease in mice following allogenic bone marrow transplantation].
Ran HH; Pan KL; Zhang R; Wang YF
Zhongguo Dang Dai Er Ke Za Zhi; 2006 Oct; 8(5):408-12. PubMed ID: 17052403
[TBL] [Abstract][Full Text] [Related]
28. [Treatment of leukemia with immunized donor cell infusion after nonmyeloablative haploidentical bone marrow transplantation].
Xu PF; Duan LN; Luo Y; Wang Z; Lu CR; Xiang PD; Lei YY
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2013 Jun; 21(3):711-5. PubMed ID: 23815928
[TBL] [Abstract][Full Text] [Related]
29. Suppression of lentivirus-mediated transgenic dendritic cells in graft-versus-host disease after allogeneic bone marrow transplantation in mice.
Xu YJ; Chen WR; Li DP; Song LX; Wu JQ; Zhang P; Li ZY; Huang YH
Genet Mol Res; 2015 Sep; 14(3):11444-55. PubMed ID: 26436385
[TBL] [Abstract][Full Text] [Related]
30. [Immune changes in type 1 diabetes animal model after syngeneic bone marrow transplantation].
Lü CL; Ouyang J
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2010 Jun; 18(3):726-30. PubMed ID: 20561438
[TBL] [Abstract][Full Text] [Related]
31. [Alloreactive NK cells enhance the effect of donor lymphocyte infusion in the management of relapsed lung cancer after haploidentical hematopoietic stem cell transplantation].
Yu JP; Sun HY; Li H; Cao S; Xin N; Ren XB
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2009 Feb; 17(1):164-9. PubMed ID: 19236771
[TBL] [Abstract][Full Text] [Related]
32. [Experimental study of Tripterygium hypoglaucum (level) Hutch on preventing acute graft-versus-host disease in bone marrow transplantation mice].
Li S; Xu KL; Li ZY; Pan XY; Sun HY; Li DP; Cao J; Du B
Zhonghua Xue Ye Xue Za Zhi; 2007 Nov; 28(11):727-30. PubMed ID: 18457261
[TBL] [Abstract][Full Text] [Related]
33. [Experimental study on blocking immune escape of leukemia cells in the recipient after bone marrow transplantation].
Hu ZB; Zhang YS; Li AX; Liu LB; Zou P
Zhonghua Xue Ye Xue Za Zhi; 2003 Aug; 24(8):402-6. PubMed ID: 14642175
[TBL] [Abstract][Full Text] [Related]
34. Elimination of the chemotherapy resistant subpopulation of 4T1 mouse breast cancer by haploidentical NK cells cures the vast majority of mice.
Frings PW; Van Elssen CH; Wieten L; Matos C; Hupperets PS; Schouten HC; Bos GM; van Gelder M
Breast Cancer Res Treat; 2011 Dec; 130(3):773-81. PubMed ID: 21274621
[TBL] [Abstract][Full Text] [Related]
35. [The distribution of donor hematopoietic stem cell and the ratio of lymphocytes from donor origin to recipient origin in recipient mice after allogeneic bone marrow transplantation].
Shen SJ; Li XY; Wang LP
Zhonghua Xue Ye Xue Za Zhi; 2005 Jul; 26(7):393-6. PubMed ID: 16251017
[TBL] [Abstract][Full Text] [Related]
36. Prolonged survival in mice with advanced tumors treated with syngeneic or allogeneic intra-bone marrow-bone marrow transplantation plus fetal thymus transplantation.
Hosaka N; Cui W; Zhang Y; Takaki T; Inaba M; Ikehara S
Cancer Immunol Immunother; 2010 Jul; 59(7):1121-30. PubMed ID: 20229083
[TBL] [Abstract][Full Text] [Related]
37. [Effect of delayed sequential bone marrow transplantation on acute graft-versus-host disease in major H-2 incompatible mouse transplantation].
Wang CL; Xu KL; Pan XY; Du B
Zhonghua Xue Ye Xue Za Zhi; 2008 Feb; 29(2):92-6. PubMed ID: 18681308
[TBL] [Abstract][Full Text] [Related]
38. [Experimental study on IL-2- and IL-15 application in allogeneic hematopoietic stem cell transplantation].
Chen GH; Wu DP; Sun AN; Yang MZ; Wang Y; Tang XW; Chang HR; Feng YF; Zhu ZL
Zhonghua Xue Ye Xue Za Zhi; 2008 Aug; 29(8):526-30. PubMed ID: 19112915
[TBL] [Abstract][Full Text] [Related]
39. Facilitation of hematopoietic recovery by bone grafts with intra-bone marrow-bone marrow transplantation.
Song C; Hisha H; Wang X; Li Q; Li M; Cui W; Guo K; Okazaki S; Mizokami T; Kato J; Cui Y; Feng W; Zhang Y; Shi M; Inaba M; Fan H; Ikehara S
Immunobiology; 2008; 213(6):455-68. PubMed ID: 18514748
[TBL] [Abstract][Full Text] [Related]
40. [An absence of donor TH17 differentiation ameliorates dermal tissue damage].
Cheng H; Song GL; Pan B; Tian J; Yan ZL; Chen W; Xu KL; Li ZY; Zeng LY
Zhonghua Yi Xue Za Zhi; 2011 Jul; 91(26):1843-6. PubMed ID: 22093788
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
